FDA approves an expanded indication for AbbVies Qulipta to prevent chronic migraines.
The U.S. Supreme Court extends by two days (until 4/21) its administrative stay of a lower courts 4/7 order that would restrict the distribution of th...
An ongoing European Medicines Agency and FDA joint initiative on information sharing involving generic drug bioequivalence study inspections adds Irel...
FDA grants traditional approval of Genentechs Polivy (polatuzumab vedotin-piiq) for combination use with four other drugs in for treating certain adul...
House Committee on Oversight and Accountability chairman James Comer begins probe into FDAs recent decision not to regulate cannabidiol products as di...
Federal Register notice: FDA announces an opportunity for public comments on an information collection extension entitled FDA Human Cells, Tissues, an...
Federal Register notice: FDA corrects a 4/11 notice on its Vaccines and Related Biological Products Advisory Committee that contained an incorrect doc...
FDA and RTI International researchers characterize data displays in prescription drug promotions to healthcare providers.
